--- title: "Chief Sales Officer David Mulham Reports Disposal of USANA Health Sciences Inc. Common Shares" description: "David Mulham, Chief Sales Officer of USANA Health Sciences Inc., has reported the disposal of common shares of the company. The full filing is available through the provided link. This news was genera" type: "news" locale: "en" url: "https://longbridge.com/en/news/251033363.md" published_at: "2025-07-31T15:04:00.000Z" --- # Chief Sales Officer David Mulham Reports Disposal of USANA Health Sciences Inc. Common Shares > David Mulham, Chief Sales Officer of USANA Health Sciences Inc., has reported the disposal of common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice. David Mulham, the Chief Sales Officer of USANA Health Sciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000896264-25-000200), on July 31, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [USNA.US - USANA Health Sciences](https://longbridge.com/en/quote/USNA.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | USANA Health Sciences Issues Amendment to Form 8-K Report | USANA Health Sciences Inc. has amended its Form 8-K report originally filed on January 8, 2026. The amendment, submitted | [Link](https://longbridge.com/en/news/275663912.md) | | Kevin Guest Returns as CEO of USANA Health Sciences | USANA Health Sciences Inc. has announced the return of Kevin Guest as Chief Executive Officer, succeeding Jim Brown, who | [Link](https://longbridge.com/en/news/271945656.md) | | USANA CIO Peter Benedict Reports Sale of Common Shares | Peter Benedict, CIO of USANA Health Sciences Inc., reported selling common shares of the company. This information was p | [Link](https://longbridge.com/en/news/269408233.md) | | Officer Benedict Sells 2,673 ($56K) Of USANA Health Sciences Inc [USNA] | Benedict Peter Officer of USANA Health Sciences Inc [USNA] filed a Form 4 on December 11, 2025 with the Securities and E | [Link](https://longbridge.com/en/news/269408561.md) | | Trust Your Gut--USANA's Probiotic Earns ConsumerLab.com Seal of Approval \| USNA Stock News | USANA's Probiotic supplement has earned the ConsumerLab.com Seal of Approval, recognizing its high standards for purity, | [Link](https://longbridge.com/en/news/269862308.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.